The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Alpha-synuclein Seed Amplification Assay Program, 2022Comparison and Cross-Validation of Alpha-synuclein Seed Aggregation Assays in Samples of Skin, Cerebrospinal Fluid, Saliva and Tears
Study Rationale: Identification of misfolded alpha-synuclein aggregates in postmortem brain samples remains a major histopathological hallmark for confirming the diagnosis of Parkinson’s disease (PD)...
-
Diversity, Equity and Inclusivity in Parkinson's research, 2022Studying Parkinson’s Disease Clinical Features, Progression and Quality of Care in Latino Patients from a Population-based Epidemiological Study in the United States
Study Rationale: Social and medical factors can affect the rates of Parkinson’s disease (PD) and how the disorder manifests in different individuals. These factors may carry different weight in...
-
Diversity, Equity and Inclusivity in Parkinson's research, 2022Racial Disparities in Parkinson’s Disease Care Among Asian Americans and Native Hawaiian/Pacific Islanders: A Retrospective Analysis of Hospitalization Data and Pilot Project for Prospective Cohort Study
Study Rationale: The state of Hawai’i is ethnically diverse, with a mix of Southeast Asian, East Asian and North Americans, in addition to distinct indigenous Native Hawaiians and Pacific Islanders...
-
Fall 2021 RFP: Expanding Biological Understanding of PD, 2022Examining Fatty Acid Imbalances in Parkinson’s Disease
Study Rationale: In people with Parkinson’s disease (PD), alpha-synuclein proteins aggregate to form structures called Lewy Bodies (LBs). These LBs have recently been found to also contain lipid...
-
Fall 2021 RFA: Promoting Diversity, Equity and Inclusion in Parkinson’s Disease Research, 2022Disparities in Neurocognitive Impairment Among Hispanics and Latinos in the United States with Parkinson’s Disease: The Role of Cardiovascular Risk
Study Rationale: In the United States, Latinos with Parkinson’s disease (PD) are more likely to have problems with memory, planning and other thinking skills than individuals of other ethnic/racial...
-
Research Grant, 2022Pharmacokinetics, Food Effects, Safety and Tolerability of Aggregation Inhibitor Anle138b in Parkinson´s Disease
Study Rationale:
Pathological alpha-synuclein aggregates, called Lewy bodies, are a hallmark of Parkinson’s disease (PD) and a promising target for therapeutics. Anle138b is a compound that inhibits...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.